Drugs / LEVMETAMFETAMINE
LEVMETAMFETAMINE
also known as
L-desoxyephedrine · l-methamphetamine · Levmetamfetamine cii · Levmetanfetamina · Levomethamphetamine
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| — | NCT00829634 | Oct 2008 → Sep 2009 | nasal cavity disorder | California Pacific Medical Center Research Institute | Completed | No outcome recorded |
Evidence & citations 8 cited values
Every value below carries the sentence it was read from. 2 sources stand behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | LEVMETAMFETAMINE | ChEMBL registry synonym — accepted as the source's own label CHEMBL1927030 ↗ |
| Known as | L-desoxyephedrine | ChEMBL registry synonym — accepted as the source's own label CHEMBL1927030 ↗ |
| Known as | l-methamphetamine | ClinicalTrials.gov intervention name — accepted as the source's own label NCT00829634 ↗ |
| Known as | Levmetamfetamine cii | ChEMBL registry synonym — accepted as the source's own label CHEMBL1927030 ↗ |
| Known as | Levmetanfetamina | ChEMBL registry synonym — accepted as the source's own label CHEMBL1927030 ↗ |
| Known as | Levomethamphetamine | ChEMBL registry synonym — accepted as the source's own label CHEMBL1927030 ↗ |
| Modality | Small molecule | — CHEMBL1927030 ↗ |
| Route | Oral | “subjects will receive an oral dose of l-methamphetamine” NCT00829634 ↗ |